Arthritis Research & Therapy volume 14, Article number: P50 (2012)
TLRs 2, 4 and 9 have been implicated in murine models and human patients of arthritis, but the other TLRs are not well-investigated. Thus, we studied TLR expression and signaling and effect of TLR ligand stimulation in peripheral blood (PB) and synovial fluid (SF) monocytes (MC) of ERA patients.
Levels of TLR2, TLR4 and TLR9 were measured by flow cytometry in ERA PBMC (n = 26), paired SFMC (n = 13) and healthy PBMC (n = 19) Real time PCR was done for TLRs 1-9 and their adaptors IRAK1, IRAK4, TRIF, TRAF3, TRAF6. PBMC and SFMC were stimulated with ligands for TLR1 (pam3-cys), 2 (peptidoglycan), 3 (polyI:C), 4 (LPS), 5 (flagellin) and 6 (zymosan). Levels of IL-6, IL-8 and MMP3 (ng/ml) were measured in the culture supernatants.
ERA PBMC had higher MFI of TLR2 [295.5(48.1-598) vs 179(68.7-442); p < 0.05] and TLR4 [448(178-2581) vs 402(229-569); p < 0.05] compared to controls. Intracellular TLR9 expression showed no significant difference between both groups. In paired samples, SFMC had higher MFI of both TLR2 [485(141-1683) vs 353(180-598); p < 0.05] and TLR4 [1016(42.4-3159) vs 513(193-2581); p < 0.05] compared to PBMC. Difference in TLR9 expression was not significant [1]. Patient PBMC (compared to healthy control) and SFMC (compared to corresponding PBMC) had higher RNA expression of TLRs1, 2, 3, 4, 5 and 6 and downstream adaptors. Patients PBMC produced significantly higher IL-6 (13.51 vs 6.54) and MMP3 (61 vs 32.9) as compared to controls on stimulation by LPS. With peptidoglycan also IL-6 (30.58 vs 10.84) and MMP-3 (102.54 vs 49.45) was higher than controls. Patient PBMCs produced more IL-6 and IL-8 compared to healthy PBMCs on stimulation with Pam3-cys, poly I:C, flagellin and zymosan. In paired samples, SFMCs showed a trend towards higher IL-6 and IL-8 production compared to PBMCs (Table 1)
Increased TLR expression and signaling on PBMC and SFMC from JIA-ERA patients may exacerbate disease by upregulating IL-6, IL-8 and MMP-3 in response to microbial/ endogenous ligands. TLR pathway is a potential therapeutic target in these patients.
Myles A, Aggarwal A: Expression of Toll-like receptors 2 and 4 is increased in peripheral blood and synovial fluid monocytes of patients with enthesitis-related arthritis subtype of juvenile idiopathic arthritis. Rheumatology. 2011, 50: 481-488. 10.1093/rheumatology/keq362.
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Myles, A., Aggarwal, A. Over expression of toll-like receptors in peripheral blood and synovial fluid monocytes of enthesitis related arthritis category of juvenile idiopathic arthritis (JIA-ERA) patients contributes to secretion of inflammatory mediators. Arthritis Res Ther 14 (Suppl 1), P50 (2012). https://doi.org/10.1186/ar3651
Published:
DOI: https://doi.org/10.1186/ar3651